Vicore Pharma Holding AB Statistics
Total Valuation
VCRE has a market cap or net worth of $250.44 million. The enterprise value is $159.00 million.
| Market Cap | 250.44M |
| Enterprise Value | 159.00M |
Important Dates
The next confirmed earnings date is Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VCRE has 281.53 million shares outstanding. The number of shares has increased by 32.83% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 281.53M |
| Shares Change (YoY) | +32.83% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.89% |
| Owned by Institutions (%) | 33.51% |
| Float | 200.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 607.74 |
| Forward PS | 160.23 |
| PB Ratio | 2.84 |
| P/TBV Ratio | 2.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 385.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.68
| Current Ratio | 12.68 |
| Quick Ratio | 12.50 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -56.99% and return on invested capital (ROIC) is -37.17%.
| Return on Equity (ROE) | -56.99% |
| Return on Assets (ROA) | -34.35% |
| Return on Invested Capital (ROIC) | -37.17% |
| Return on Capital Employed (ROCE) | -61.14% |
| Weighted Average Cost of Capital (WACC) | 4.75% |
| Revenue Per Employee | $8,959 |
| Profits Per Employee | -$1.13M |
| Employee Count | 46 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VCRE has paid $26,723 in taxes.
| Income Tax | 26,723 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.09 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 10.66 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 34.12 |
| Average Volume (20 Days) | 35,121 |
Short Selling Information
The latest short interest is 4,238, so 0.00% of the outstanding shares have been sold short.
| Short Interest | 4,238 |
| Short Previous Month | 11,674 |
| Short % of Shares Out | 0.00% |
| Short % of Float | 0.00% |
| Short Ratio (days to cover) | 0.14 |
Income Statement
In the last 12 months, VCRE had revenue of $412,092 and -$51.80 million in losses. Loss per share was -$0.20.
| Revenue | 412,092 |
| Gross Profit | 412,092 |
| Operating Income | -54.05M |
| Pretax Income | -51.77M |
| Net Income | -51.80M |
| EBITDA | n/a |
| EBIT | -54.05M |
| Loss Per Share | -$0.20 |
Balance Sheet
The company has $93.44 million in cash and no debt, with a net cash position of $93.44 million or $0.33 per share.
| Cash & Cash Equivalents | 93.44M |
| Total Debt | n/a |
| Net Cash | 93.44M |
| Net Cash Per Share | $0.33 |
| Equity (Book Value) | 88.08M |
| Book Value Per Share | 0.31 |
| Working Capital | 88.02M |
Cash Flow
| Operating Cash Flow | -46.07M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -46.07M |
| FCF Per Share | -$0.16 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -13,116.96% |
| Pretax Margin | -12,563.26% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VCRE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -32.83% |
| Shareholder Yield | -32.83% |
| Earnings Yield | -20.68% |
| FCF Yield | -18.39% |
Analyst Forecast
The average price target for VCRE is $29.16, which is 224.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $29.16 |
| Price Target Difference | 224.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | -8.41% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |